🇺🇸 FDA
Patent

US 11186822

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

granted A61KA61K2039/804A61K2239/31

Quick answer

US patent 11186822 (Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)) held by Precision BioSciences, Inc. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision BioSciences, Inc.
Grant date
Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2039/804, A61K2239/31, A61K2239/38, A61K2239/48